WHIS on November 04-06, 2025 in Boston, United States

Formerly the Women's Health Innovation Summit, WHIS brings together the entire women's health ecosystem and incorporates previous FemTech and Reproductive Health events. It consolidates multi-sector efforts to accelerate industry-wide solutions across women's health, mirroring a critical moment of convergence in women's health innovation.

WHIS 2025 unites a diverse range of stakeholders: start-ups and scale ups, investors, pharmaceutical and biotech multinationals, payers, public sector and regulatory bodies, with service providers like CROs, legal advisors, and consultancy groups. The event's mission is clear: tackle persistent disparities by fostering commercial, regulatory, clinical, and technological insight sharing across a comprehensive women's health agenda.

What's On and Who's Talking

. Innovation Showcase: At the beating heart of WHIS, 20 trailblazing start ups will pitch across two categories - Digital Health and FemTech and Therapeutics and Med Devices - to an audience of 800+ decision makers

. WHIS Innovators Academy: New in 2025, this pre-event deep dive day equips emerging companies with mission critical skills, from IP, branding, and reimbursement, to regulatory fast tracking, market strategy, and trial recruitment

. Keynotes, Panels and Presentations: Accelerate growth, drive adoption, and deliver measurable outcomes across the entire care spectrum by updating your strategy in line with the latest insights from industry leaders. From unlocking funding pathways and payer strategies, to navigating regulatory hurdles and advancing clinical validation, these sessions are designed to help you supercharge your progress.

. Structured 1:2:1 Networking: Forge commercial collaborations from seed to global distribution attendees by pre-scheduling meetings with the partner that matter most to you.

Why It Matters to the Healthcare Community

WHIS addresses long standing critical investment signals: reproductive health markets, such as endometriosis management, are now projected to reach into the hundreds of billions annually, a figure amplified by unmet needs and underinvestment. For founders and investors, it offers both runway and runway acceleration: showcase opportunities, high level investor and payer access, coupled with actionable insights on pathways to scale, reimbursement, and regulatory navigation.

Who Attends and Why Their Voice Counts

. Start ups and SMEs: Will find a launchpad for visibility, partnerships, and funding. The dedicated Innovation Showcase is a proven platform for finalists to attract investment.

. Payers and Providers: Gain early sight of clinical and digital tools that can improve women's health outcomes while reining in cost drivers, particularly in maternal and chronic care sectors.

. Big Pharma and Biotech: Engage with emerging technologies and pipeline prospects that complement your portfolios and explore acquisition and licensing pathways.

. Service Providers and Policymakers: Exchange regulatory, reimbursement, legal, and market access strategies that support scaling throughout lifespan-focused care.

WHIS 2025 marks a pivotal chapter in women's health. By weaving together digital, clinical, commercial, and regulatory threads into one cohesive platform, it offers a rare opportunity for women's health leaders to not only showcase innovations but to implement them and scale them as we deliver the future of health for women.

URL:

Tickets: https://go.evvnt.com/3100983-0?pid=10008

Prices:

Tier 1 - Academics, NPOs, Payers, Healthcare Providers and Clinics Advocacy Groups: USD 699.00,

Tier 2 - Start Ups (Pre-Revenue) and Start Ups (Seed - Series A): USD 899.00,

Tier 3 - Small and Medium-Sized Enterprises (Revenue Generating, Series B+) and Investors (Angel, VC): USD 1299.00,

Tier 4 - Pharmaceutical Companies, Med Device Companies, Multinational Consumer Brands, Retailers, Service Providers, including Consultants, CROs, Marketing Agencies, Law Firms and Investors (PE, Banks, Financial Institutions): USD 2899.00

Speakers: Dianne Balon, SVP of Government, BLUE CROSS, Tamara Orlova, Chief Financial Officer, FLO HEALTH, Roohi Jeelani, Chief Growth Officer, KINDBODY, Katie Ryan, Senior Innovation Strategist, HUMANA, Maxine Carrington, Chief People Officer, NORTHWELL HEALTH, Lynn Mason, Chief Executive Officer, IVI RMA GLOBAL, Lucy Perez, Senior Partner - Life Sciences, MCKINSEY and COMPANY, Neel Shah, Chief Medical Officer, MAVEN CLINIC

Category: Conferences | Health

Date and Time: 4th November 2025 at 8:00 am to 6th November 2025 at 5:00 pm